Work progresses on our new $20 million home Spring 2021
Construction continues on our $20 million expansion, progressing well toward a September completion.

The new two-story structure, which is connected on both sides to our two existing buildings, will increase usable space by 40%, including 15,000 square feet of new laboratories. It will provide a new main entrance, offices and a 200-seat event space.

Managed by the Baruch S. Blumberg Institute, which is the Hepatitis B Foundation's research arm, the PABC is home to both organizations, plus more than 40 member companies. The Institute's scientists are focused on hepatitis B and liver cancer. For more details, images and a time-lapse video, please click here.
$17 million invested this spring in fund to support PABC-member companies 
Daiichi Sankyo, a global pharmaceutical company, has agreed to invest $10 million in the Hatch Biofund, which was created by the Blumberg Institute as a companion to their incubator and bioaccelerator. With input from a scientific advisory committee and an investment committee, the fund will invest in PABC-member companies that apply for financial support to continue their R&D and other business activities.

The PABC announced a second major investment in the Hatch Biofund, $5 million, recently by the Bucks County Employees’ Retirement Board. Also last month, Provco Group LLC of Villanova agreed to make a $2 million investment in the Hatch fund. The fund’s leadership hope to raise $50 million by year's end. To read more, please click here.
PABC's popular Entrepreneur Spotlight to be held July 22
The very popular annual
PABC Entrepreneur Spotlight will be held this year on July 22 at 4 p.m.

Much like TV's "Shark Tank," this free event puts some entrepreneurs to the test. First, they present their concept, then answer questions from a panel of experts. We will have breakout rooms and a networking session at the conclusion.

Please save the date and look for (no cost) registration info on our social media and the event's website in the very near future.
Blumberg Institute and Haub School of Business at Saint Joseph’s University team up to promote a Pharmaceutical and Healthcare Marketing MBA program

The Baruch S. Blumberg Institute and the Haub School of Business at Saint Joseph’s University have a new partnership to promote the School's Pharmaceutical and Healthcare Marketing MBA to industry professionals. A global leader in translational life sciences research, the Blumberg Institute manages and is located in the PABC. Please read more here.
Brandywine Realty Trust selects PABC to run new Philadelphia incubator
Brandywine Realty Trust, in partnership with the PABC, recently announced B.Labs—a Life Science incubator at Cira Centre directly adjacent to Brandywine’s 14 acre $3.5 billion Schuylkill Yards neighborhood in University City, Philadelphia.

B.Labs will provide high quality innovation, collaboration, and research space that creates growth capacity for start-up, early-stage, fast-growing and established Life Science industry leaders.

Capitalizing on University City’s intense demand for flexible, plug and play lab and research space, the 50,000 square foot B.Labs will commence construction immediately with an opening date scheduled in the fourth quarter of 2021. Please read more here.
PABC Company Spotlight shares news from our companies
Because the success stories of PABC member companies are so effective in telling our story, we've created the Company Spotlight.

Among recent items was news that researchers with Neuropathix Inc. (a member company) and Temple University found that a novel CBD analog shows promise for pain relief. Also, Flowmetric's mobile lab was used for COVID-19 testing at Neumann University and a number of other area institutions.

Please read more here and consider submitting your PABC-member company's news to Ed Tate, edward.tate@pabiotechbc.org.
Nov. 4 is the date of our annual Regional Biotechnology Conference this year
The PABC's Regional Biotechnology Conference, a popular annual event, will be held this year on Nov. 4 as a hybrid event. As in prior years, it will be open to everyone interested and there will be no registration fee.

Last year the conference was a virtual event and attracted a larger-then-ever audience, including participants from overseas. Our presenters, who were experts in the pharmaceutical and financial industries, provided some extremely valuable insights and information. Please keep an eye out for more details in this newsletter's next edition and plan to participate on Nov. 4!
PABC Social Media
The PABC is beefing up our Instagram account with the help of Maria Valentino, an expert in social media. She also is CEO of Maria Valentino LLC, a PABC-member company.

Please make sure to follow the PABC's social media accounts (Instagram, Twitter, Facebook, LinkedIn) to stay up to date with the latest news and information.
The PABC is one of the nation's most successful life sciences incubators.
A nonprofit organization, the PABC is dedicated to the creation of a world-class biotechnology center; to the promotion of regional economic development and job creation; and to the education and training of tomorrow’s researchers.

The Pennsylvania Biotechnology Center (PABC)
3805 Old Easton Road Doylestown, PA 18902
215-489-4900 info@pabiotechbc.org